Atezolizumab and Bevacizumab in Patients With Recurrent or Metastatic Squamous-cell Carcinoma of the Head and Neck

Condition:   Head and Neck Neoplasms
Interventions:   Drug: Atezolizumab;   Drug: Bevacizumab
Sponsor:   Centre Leon Berard
Not yet recruiting

http://bit.ly/2t0yxU0